Susceptibility-testing criteria
Lancet Infect Dis
.
2011 Aug;11(8):584.
doi: 10.1016/S1473-3099(11)70173-6.
Authors
Glenn S Tillotson
1
,
Joni Tillotson
Affiliation
1
Optimer Pharmaceuticals, San Diego, CA, USA. gtillotson@optimerpharma.com
PMID:
21798458
DOI:
10.1016/S1473-3099(11)70173-6
No abstract available
Publication types
Letter
MeSH terms
Anti-Bacterial Agents / pharmacology*
Humans
Microbial Sensitivity Tests / standards*
Substances
Anti-Bacterial Agents